Progression-free survival after high-dose radiochemotherapy followed by autologous stem cell transplantation (ASCT) and interferon-α (IFN) maintenance in MCL. Patients assigned to stem cell transplantation experience significantly longer progression-free survival (log-rank test). Solid line indicates ASCT; broken line, IFN. Vertical bars indicate 95% confidence intervals for progression-free survival.